Breeman Linda D, van der Pal Sylvia, Verrips Gijsbert H W, Baumann Nicole, Bartmann Peter, Wolke Dieter
Department of Psychology, University of Warwick, Coventry, CV4 7AL, UK.
Department of Youth & Family, Utrecht University, Utrecht, The Netherlands.
Qual Life Res. 2017 Apr;26(4):935-943. doi: 10.1007/s11136-016-1410-7. Epub 2016 Sep 22.
Although survival after very preterm birth (VP)/very low birth weight (VLBW) has improved, a significant number of VP/VLBW individuals develop physical and cognitive problems during their life course that may affect their health-related quality of life (HRQoL). We compared HRQoL in VP/VLBW cohorts from two countries: The Netherlands (n = 314) versus Germany (n = 260) and examined whether different neonatal treatment and rates of disability affect HRQoL in adulthood.
To analyse whether cohorts differed in adult HRQoL, linear regression analyses were performed for three HRQoL outcomes assessed with the Health Utilities Index 3 (HUI3), the London Handicap Scale (LHS), and the WHO Quality of Life instrument (WHOQOL-BREF). Stepwise hierarchical linear regression was used to test whether neonatal physical health and treatment, social environment, and intelligence (IQ) were related to VP/VLBW adults' HRQoL and cohort differences.
Dutch VP/VLBW adults reported a significantly higher HRQoL on all three general HRQoL measures than German VP/VLBW adults (HUI3: .86 vs .83, p = .036; LHS: .93 vs. .90, p = .018; WHOQOL-BREF: 82.8 vs. 78.3, p < .001). Main predictor of cohort differences in all three HRQoL measures was adult IQ (p < .001).
Lower HRQoL in German versus Dutch adults was related to more cognitive impairment in German adults. Due to different policies, German VP/VLBW infants received more intensive treatment that may have affected their cognitive development. Our findings stress the importance of examining effects of different neonatal treatment policies for VP/VLBW adults' life.
尽管极早产(VP)/极低出生体重(VLBW)后的存活率有所提高,但仍有相当数量的VP/VLBW个体在其生命过程中出现身体和认知问题,这可能会影响他们与健康相关的生活质量(HRQoL)。我们比较了来自两个国家的VP/VLBW队列的HRQoL:荷兰(n = 314)与德国(n = 260),并研究了不同的新生儿治疗方法和残疾率是否会影响成年后的HRQoL。
为了分析队列在成年HRQoL方面是否存在差异,我们对使用健康效用指数3(HUI3)、伦敦残疾量表(LHS)和世界卫生组织生活质量量表(WHOQOL - BREF)评估的三个HRQoL结果进行了线性回归分析。采用逐步分层线性回归来测试新生儿身体健康和治疗、社会环境以及智力(IQ)是否与VP/VLBW成年人的HRQoL和队列差异相关。
荷兰VP/VLBW成年人在所有三项一般HRQoL测量指标上的HRQoL均显著高于德国VP/VLBW成年人(HUI3:0.86对0.83,p = 0.036;LHS:0.93对0.90,p = 0.018;WHOQOL - BREF:82.8对78.3,p < 0.001)。所有三项HRQoL测量指标队列差异的主要预测因素是成人IQ(p < 0.001)。
德国成年人的HRQoL低于荷兰成年人与德国成年人更多的认知障碍有关。由于政策不同,德国VP/VLBW婴儿接受了更强化的治疗,这可能影响了他们的认知发展。我们的研究结果强调了研究不同新生儿治疗政策对VP/VLBW成年人生活影响的重要性。